vs

Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $20.6M, roughly 1.3× Pulmonx Corp). First Bancorp, Inc runs the higher net margin — 39.4% vs -66.3%, a 105.7% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -8.7%). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -0.5%).

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

FNLC vs LUNG — Head-to-Head

Bigger by revenue
FNLC
FNLC
1.3× larger
FNLC
$25.8M
$20.6M
LUNG
Growing faster (revenue YoY)
FNLC
FNLC
+26.2% gap
FNLC
17.5%
-8.7%
LUNG
Higher net margin
FNLC
FNLC
105.7% more per $
FNLC
39.4%
-66.3%
LUNG
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
-0.5%
LUNG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FNLC
FNLC
LUNG
LUNG
Revenue
$25.8M
$20.6M
Net Profit
$10.2M
$-13.7M
Gross Margin
77.9%
Operating Margin
48.1%
-40.9%
Net Margin
39.4%
-66.3%
Revenue YoY
17.5%
-8.7%
Net Profit YoY
39.7%
5.5%
EPS (diluted)
$0.91
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNLC
FNLC
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$25.8M
$22.6M
Q3 25
$24.5M
$21.5M
Q2 25
$22.5M
$23.9M
Q1 25
$21.8M
$22.5M
Q4 24
$22.0M
$23.8M
Q3 24
$20.5M
$20.4M
Q2 24
$19.2M
$20.8M
Net Profit
FNLC
FNLC
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$10.2M
$-10.4M
Q3 25
$9.1M
$-14.0M
Q2 25
$8.1M
$-15.2M
Q1 25
$7.1M
$-14.4M
Q4 24
$7.3M
$-13.2M
Q3 24
$7.6M
$-14.1M
Q2 24
$6.2M
$-15.3M
Gross Margin
FNLC
FNLC
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
FNLC
FNLC
LUNG
LUNG
Q1 26
-40.9%
Q4 25
48.1%
-43.8%
Q3 25
45.2%
-66.9%
Q2 25
43.7%
-62.0%
Q1 25
39.3%
-64.6%
Q4 24
39.5%
-56.5%
Q3 24
44.6%
-69.3%
Q2 24
38.8%
-75.2%
Net Margin
FNLC
FNLC
LUNG
LUNG
Q1 26
-66.3%
Q4 25
39.4%
-46.1%
Q3 25
37.0%
-64.9%
Q2 25
35.8%
-63.6%
Q1 25
32.5%
-64.1%
Q4 24
33.1%
-55.4%
Q3 24
36.9%
-69.4%
Q2 24
32.1%
-73.7%
EPS (diluted)
FNLC
FNLC
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$0.91
$-0.25
Q3 25
$0.81
$-0.34
Q2 25
$0.72
$-0.38
Q1 25
$0.63
$-0.36
Q4 24
$0.66
$-0.33
Q3 24
$0.68
$-0.36
Q2 24
$0.55
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNLC
FNLC
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$61.6M
Total DebtLower is stronger
$95.5M
$37.3M
Stockholders' EquityBook value
$283.1M
$45.8M
Total Assets
$3.2B
$120.0M
Debt / EquityLower = less leverage
0.34×
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNLC
FNLC
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$69.8M
Q3 25
$76.5M
Q2 25
$75.5M
Q1 25
$74.6M
Q4 24
$70.9M
Q3 24
$63.3M
Q2 24
$63.5M
Total Debt
FNLC
FNLC
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$95.5M
$37.1M
Q3 25
$95.5M
$37.1M
Q2 25
$95.0M
$37.1M
Q1 25
$70.0M
$37.2M
Q4 24
$95.0M
$37.2M
Q3 24
$95.0M
$37.2M
Q2 24
$70.0M
$37.2M
Stockholders' Equity
FNLC
FNLC
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$283.1M
$54.1M
Q3 25
$274.6M
$60.0M
Q2 25
$265.5M
$69.1M
Q1 25
$259.7M
$77.7M
Q4 24
$252.5M
$85.8M
Q3 24
$256.8M
$93.9M
Q2 24
$244.7M
$101.2M
Total Assets
FNLC
FNLC
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$3.2B
$129.3M
Q3 25
$3.2B
$138.3M
Q2 25
$3.2B
$147.2M
Q1 25
$3.2B
$150.7M
Q4 24
$3.2B
$162.8M
Q3 24
$3.1B
$167.4M
Q2 24
$3.1B
$172.6M
Debt / Equity
FNLC
FNLC
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.34×
0.69×
Q3 25
0.35×
0.62×
Q2 25
0.36×
0.54×
Q1 25
0.27×
0.48×
Q4 24
0.38×
0.43×
Q3 24
0.37×
0.40×
Q2 24
0.29×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNLC
FNLC
LUNG
LUNG
Operating Cash FlowLast quarter
$37.8M
Free Cash FlowOCF − Capex
$34.6M
FCF MarginFCF / Revenue
133.9%
Capex IntensityCapex / Revenue
12.5%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNLC
FNLC
LUNG
LUNG
Q1 26
Q4 25
$37.8M
$-7.1M
Q3 25
$12.9M
$-8.2M
Q2 25
$7.4M
$-3.9M
Q1 25
$2.2M
$-13.2M
Q4 24
$26.0M
$-6.7M
Q3 24
$9.8M
$-7.2M
Q2 24
$6.4M
$-5.8M
Free Cash Flow
FNLC
FNLC
LUNG
LUNG
Q1 26
Q4 25
$34.6M
$-7.1M
Q3 25
$12.6M
$-8.3M
Q2 25
$7.2M
$-4.0M
Q1 25
$828.0K
$-13.5M
Q4 24
$24.6M
$-6.8M
Q3 24
$9.6M
$-7.7M
Q2 24
$6.3M
$-6.2M
FCF Margin
FNLC
FNLC
LUNG
LUNG
Q1 26
Q4 25
133.9%
-31.4%
Q3 25
51.4%
-38.4%
Q2 25
32.1%
-16.6%
Q1 25
3.8%
-60.0%
Q4 24
111.7%
-28.8%
Q3 24
47.0%
-37.6%
Q2 24
32.9%
-30.0%
Capex Intensity
FNLC
FNLC
LUNG
LUNG
Q1 26
Q4 25
12.5%
0.1%
Q3 25
1.2%
0.4%
Q2 25
0.6%
0.2%
Q1 25
6.2%
1.3%
Q4 24
6.7%
0.5%
Q3 24
0.5%
2.0%
Q2 24
0.3%
2.3%
Cash Conversion
FNLC
FNLC
LUNG
LUNG
Q1 26
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons